Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Insulet Omnipod 6 data puts PODD back in focus as automated insulin delivery moves toward type 2 diabetes Read how Insulet Omnipod 6 data could reshape automated insulin delivery, type 2 diabetes care and PODD stock sentiment. Find out what changes next in 2026. byVenkateshJune 8, 2026